Klaus Stockemann PhD, MBA

Dr. Stöckemann is the co-founder of Peppermint Venture Partners and one of the managing partners in the Charite Biomedical Fund. As a former General Partner in the international Healthcare Venture Team of 3i, he is a highly experienced venture capitalist. He has been active for more than 10 year in the Venture Capital industry and was responsible for more than 12 investments during his tenure at 3i. His track record at 3i includes the IPO of companies like Epigenomics, Jerini and Santhera as well as the trade sales of Evotec Neuroscience, Amaxa and Elbion.